Metabolic biomarkers of response of mantle cell lymphoma to bruton tyrosine kinase inhibition

Ended Grant Awarded Last action

Award ID
R01CA228457
Recipient
Awarding agency
Obligated
$2,480,221

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $25,112
Amendment $452,054
Amendment $0
Amendment $492,237
Amendment $40,188
Amendment $452,049
Amendment $501,912
Original award $516,669

Subawards

Subrecipient Amount Awarded
Fox Chase Cancer Center Mariusz A. Wasik, M.D. (Principal Investigator on this grant application). Dr. Wasik, a Professor in the Department of Pathology at Fox Chase Cancer Center… $7,070
Fox Chase Chemical Diversity Center Inc. $127,270

Quick answers

Who received award R01CA228457?

R01CA228457 was awarded to The Trustees Of The University Of Pennsylvania by National Cancer Institute (National Institutes of Health) on March 9, 2020.

How much is award R01CA228457 worth?

$2,480,221 has been obligated on R01CA228457.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award